CD34 and Miyoshi myopathy: Usually, a successful collection of up to three sufficient PBSC grafts (> 2.0–2.5 × 106 CD34+ cells/kg body weight [bw] per graft) from MM patients can be achieved when the PBSC collection is performed after induction treatment i.e., prior to the first HD/ASCT [13, 14].